108 related articles for article (PubMed ID: 15760733)
1. Spectrofluorimetric study of eflucimibe-gamma-cyclodextrin inclusion complex.
Mesplet N; Morin P; Ribet JP
Eur J Pharm Biopharm; 2005 Apr; 59(3):523-6. PubMed ID: 15760733
[TBL] [Abstract][Full Text] [Related]
2. A spectroscopic study of the inclusion of azulene by beta- and gamma-cyclodextrins.
Abou-Zied OK
Spectrochim Acta A Mol Biomol Spectrosc; 2005 Nov; 62(1-3):245-51. PubMed ID: 16257721
[TBL] [Abstract][Full Text] [Related]
3. Investigation of curcumin-cyclodextrin inclusion complexation in aqueous solutions containing various alcoholic co-solvents and alginates using an UV-VIS titration method. Studies of curcumin and curcuminoides, XXXV.
Hegge AB; Másson M; Kristensen S; Tønnesen HH
Pharmazie; 2009 Jun; 64(6):382-9. PubMed ID: 19618675
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the complexation of gemfibrozil with gamma- and hydroxypropyl-gamma-cyclodextrins.
Fernández L; Martínez-Ohárriz MC; Martín C; Vélaz I; Sánchez M; Zornoza A
J Pharm Biomed Anal; 2008 Aug; 47(4-5):943-8. PubMed ID: 18423939
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of pyrene phospholipid/gamma-cyclodextrin complex.
Tanhuanpää K; Cheng KH; Anttonen K; Virtanen JA; Somerharju P
Biophys J; 2001 Sep; 81(3):1501-10. PubMed ID: 11509363
[TBL] [Abstract][Full Text] [Related]
6. Inclusion complexes of alpha- and gamma-cyclodextrins and the herbicide norflurazon: I. Preparation and characterisation. II. Enhanced solubilisation and removal from soils.
Villaverde J; Pérez-Martínez JI; Maqueda C; Ginés JM; Morillo E
Chemosphere; 2005 Jul; 60(5):656-64. PubMed ID: 15963804
[TBL] [Abstract][Full Text] [Related]
7. A three step supercritical process to improve the dissolution rate of eflucimibe.
Rodier E; Lochard H; Sauceau M; Letourneau JJ; Freiss B; Fages J
Eur J Pharm Sci; 2005 Oct; 26(2):184-93. PubMed ID: 16081259
[TBL] [Abstract][Full Text] [Related]
8. Spectroscopic investigation on the inclusion complex formation between amisulpride and γ-cyclodextrin.
Negi JS; Singh S
Carbohydr Polym; 2013 Feb; 92(2):1835-43. PubMed ID: 23399226
[TBL] [Abstract][Full Text] [Related]
9. Determinations of the inclusion complex between gossypol and beta-cyclodextrin.
Shen YL; Ying W; Yang SH; Wu LM
Spectrochim Acta A Mol Biomol Spectrosc; 2006 Sep; 65(1):169-72. PubMed ID: 16877036
[TBL] [Abstract][Full Text] [Related]
10. Study on the inclusion complex between beta-cyclodextrin and celecoxib by spectrofluorimetry and its analytical application.
Manzoori JL; Abdolmohammad-Zadeh H; Amjadi M
Farmaco; 2005; 60(6-7):575-81. PubMed ID: 15925366
[TBL] [Abstract][Full Text] [Related]
11. Evolution of the interaction of a new chemical entity, eflucimibe, with gamma-cyclodextrin during kneading process.
Gil A; Chamayou A; Leverd E; Bougaret J; Baron M; Couarraze G
Eur J Pharm Sci; 2004 Oct; 23(2):123-9. PubMed ID: 15451000
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of cyclodextrin solubilization of drugs.
Loftsson T; Hreinsdóttir D; Másson M
Int J Pharm; 2005 Sep; 302(1-2):18-28. PubMed ID: 16099118
[TBL] [Abstract][Full Text] [Related]
13. Binding of dimethyl 2,3-naphthalenedicarboxylate with alpha-, beta- and gamma-cyclodextrins in aqueous solution.
Alvariza C; Usero R; Mendicuti F
Spectrochim Acta A Mol Biomol Spectrosc; 2007 Jun; 67(2):420-9. PubMed ID: 16965929
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
15. 1H-NMR study of the inclusion processes for alpha- and gamma-cyclodextrin with fenbufen.
Bratu I; Gavira-Vallejo JM; Hernanz A
Biopolymers; 2005 Apr; 77(6):361-7. PubMed ID: 15690411
[TBL] [Abstract][Full Text] [Related]
16. Determination of the binding constant of indomethacin-beta-cyclodextrin complex by capillary electrophoresis: experimental optimization and temperature study.
Acosta G; Linares D; Olsina R; Martínez LD; Gomez MR
Pharmazie; 2007 Nov; 62(11):847-52. PubMed ID: 18065101
[TBL] [Abstract][Full Text] [Related]
17. Improvement of solubility of C70 by complexation with cyclomaltononaose (delta-cyclodextrin).
Furuishi T; Fukami T; Nagase H; Suzuki T; Endo T; Ueda H; Tomono K
Pharmazie; 2008 Jan; 63(1):54-7. PubMed ID: 18271304
[TBL] [Abstract][Full Text] [Related]
18. Inclusion complex of a Bcl-2 inhibitor with cyclodextrin: characterization, cellular accumulation, and in vivo antitumor activity.
Zhang Z; Wu G; Gao J; Song T
Mol Pharm; 2010 Aug; 7(4):1348-54. PubMed ID: 20550194
[TBL] [Abstract][Full Text] [Related]
19. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometric study of the ionized C60: (gamma-Cyclodextrin)2 inclusion complex by collision induced dissociation.
Greisch JF; Kyritsoglou S; Leyh B; De Pauw E
J Mass Spectrom; 2008 Feb; 43(2):242-50. PubMed ID: 17937447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
